N-Acylethanolamines: Linking Metabolism, Inflammation & Brain Health

The Emerging Role of N-Acylethanolamines in Metabolic Wellness

The intricate connection between what we eat, how our bodies apply energy, and our overall health is increasingly being understood through the lens of lipid signaling. Among these signaling molecules, N-acylethanolamines (NAEs) are gaining recognition for their diverse roles in regulating appetite, energy balance, inflammation, and even cognitive function. These naturally occurring compounds, produced by combining fatty acids with ethanolamine, are not simply passive byproducts of metabolism, but active communicators within the body, influencing a wide range of physiological processes. Understanding NAEs offers potential recent avenues for supporting metabolic health and addressing conditions like obesity, chronic pain, and neurodegenerative diseases.

What Are N-Acylethanolamines?

NAEs are a class of bioactive lipid mediators. Their creation begins with the transfer of an acyl chain to phosphatidylethanolamine (PE), forming N-acyl-phosphatidylethanolamine (NAPE). This process is facilitated by enzymes like cytosolic phospholipase A₂ε (cPLA₂ε) and phospholipase A and acyltransferase (PLAAT). NAPE is then converted into NAEs, primarily by NAPE-hydrolyzing phospholipase D (NAPE-PLD), though alternative pathways involving other enzymes also exist. Uyama et al. (2025) detail these biosynthetic pathways, highlighting the complexity of NAE production.

The specific effects of an NAE depend on the fatty acid it contains. Anandamide (AEA), a well-studied NAE, interacts with cannabinoid receptors, whereas others like N-palmitoylethanolamine (PEA) and N-oleoylethanolamine (OEA) primarily act through different pathways, including activation of peroxisome proliferator-activated receptor-α (PPARα).¹ PEA, OEA, and stearolyethanolamide (SEA) are typically more abundant in tissues than anandamide and exert biological effects through PPARα signaling rather than direct activation of cannabinoid receptors.

NAEs and Inflammation: A Key Connection

Several NAEs demonstrate anti-inflammatory properties, a crucial aspect given the link between chronic inflammation and metabolic disorders. PEA, originally isolated from soybeans, eggs, and peanuts, has shown promise in preclinical and clinical settings for managing inflammatory conditions, chronic pain, and neurodegeneration. Its effects are largely attributed to its interaction with PPARα signaling pathways.⁴ Currently available as a natural food supplement in the US and Europe, PEA is used by consumers for chronic pain management. NAEs can also influence inflammatory signaling by reducing pro-inflammatory cytokine production and modulating immune regulation.

OEA, produced in the small intestine after dietary fat intake, also binds to PPARα, contributing to appetite suppression. Dysfunction in OEA signaling may be linked to weight gain and obesity.⁴ OEA can also interact with receptors like GPR119, influencing satiety signaling and energy balance.

Beyond Metabolism: NAEs and Brain Health

The influence of NAEs extends to cognitive function. Docosahexaenoylethanolamide (synaptamide), derived from docosahexaenoic acid (an omega-3 fatty acid), promotes the formation of new neurons and synapses through activation of G-protein coupled receptor 110 (GPR110).⁴ This signaling pathway is linked to increased neurogenesis, neurite outgrowth, and synapse formation.

NAEs also play a role in regulating neuroinflammation. Studies suggest that increased levels of NAEs like AEA, OEA, PEA, and DHEA in the brain can influence immune responses by reducing glial activation, potentially preventing the release of pro-inflammatory cytokines. These effects involve multiple signaling targets, including cannabinoid receptors, transient receptor potential channels like TRPV1, and nuclear receptors like PPARα. Research has also noted dysregulated brain NAE levels in neurological disorders, with elevated AEA levels observed in cerebrospinal fluid samples from patients with multiple sclerosis and Parkinson’s disease.²

Dietary Sources and Metabolic Pathways

NAEs are found in both plant and animal sources. OEA is abundant in wheat, flour, cocoa, and coffee, while PEA is found in corn, tomatoes, peanuts, soybeans, and cotton seeds.² Animal products like eggs, chicken, and beef provide AEA, along with DHEA and eicosapentaenoylethanolamine (EPEA).

Within cells, NAE concentrations are carefully regulated through biosynthesis and degradation. Caloric intake and dietary fat composition influence the activity of enzymes involved in NAE biosynthesis, including cPLA2ε and PLAAT. NAEs can also undergo oxidative metabolism by enzymes like cyclooxygenases (COX), lipoxygenases (LOX), and cytochrome P450 enzymes, producing additional lipid mediators. Pharmacological inhibition of fatty acid amide hydrolase (FAAH), the primary enzyme responsible for breaking down AEA, increases endogenous NAE levels, and has been investigated as a potential therapeutic strategy, though safety concerns have limited its widespread approval.

Current Research and Future Directions

While research on NAEs is promising, much of the existing data comes from animal models. Further studies involving human cohorts are needed to clarify tissue-specific regulation, compensatory pathways, and the long-term safety and efficacy of targeting NAE metabolism.^1,3 The presence of multiple biosynthetic and metabolic pathways for NAEs also complicates research, highlighting the need for more selective pharmacological tools to manipulate specific components of the NAE signaling network.

Ongoing research continues to reveal new opportunities for targeting lipid signaling networks in metabolic, inflammatory, and neurological disorders. Mock et al. (2023) provide a comprehensive overview of the biological activities and metabolism of NAEs, emphasizing their therapeutic potential.

What’s Next: Refining Our Understanding of NAEs

The field of NAE research is rapidly evolving. Future studies will likely focus on identifying specific NAE signatures associated with different disease states, developing more targeted therapies to modulate NAE signaling, and conducting large-scale clinical trials to evaluate the efficacy of NAE-based interventions. Researchers are also exploring the potential of personalized nutrition strategies to optimize NAE levels through dietary modifications. Continued investigation into these versatile lipid mediators promises to unlock new approaches for promoting metabolic health and overall well-being.